Search

everythinglearnresearchcommunity

for

Search:↓

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Cepharanthine helps reduce cell aging caused by the cancer drug Doxorubicin by boosting cell cleanup processes.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

The combined treatment of Finasteride and Doxazosin affects prostate tissue by reducing cell growth and altering hormone levels.

ZD1839 can cause skin issues like acne and hair changes.

Dutasteride effectively treats benign prostatic hyperplasia but isn't approved for preventing prostate cancer.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

The anti-viral drug Elvitegravir may protect brain cells from damage related to neurodegenerative diseases.

M50054 may help treat hepatitis and hair loss from chemotherapy.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

NSC167409 can effectively inhibit the virus causing hand, foot, and mouth disease.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

HDAC inhibitors like Vorinostat and Entinostat may encourage hair regrowth and could be new treatments for hair loss conditions.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Early diagnosis and treatment of EGFR inhibitor-induced folliculitis decalvans can prevent permanent hair loss.

Intravenous arsenic is safe and effective for treating certain blood cancers.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

Erlotinib can cause hair loss and texture changes.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

Upadacitinib effectively treated severe hair loss in a child.